Current Medicinal Chemistry

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back Subscribe
Translate in Chinese
Research Article

Core Neuroinflammatory Pathways Contributing to Delayed Encephalopathy After Acute Carbon Monoxide Poisoning Revealed by Multi-omics and Single Nucleus RNA-Seq

Author(s): Jinlan Li, Jun Li, Junming Fu, Chuying Huang, Wenqi Lv, Chunlong Zhang, Tianjie Tian, Qunhui Liu, Shijun Yang, Yong Tan, Guogen Sun, Ying Xiang, Guoquan Huang* and Ning Wang*

Volume 33, Issue 1, 2026

Published on: 07 July, 2025

Page: [174 - 196] Pages: 23

DOI: 10.2174/0109298673407372250623101809

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Introduction: The pathogenesis of Delayed Encephalopathy After Acute Carbon Monoxide Poisoning (DEACMP) remains mysterious, and specific predictive markers are lacking. This study aimed to elucidate the molecular underpinnings and identify predictive biomarkers of DEACMP through multi- -omics and single-nucleusRNA sequencing (snRNA-seq).

Methods: Clinical data and blood samples were collected from 105 participants. Untargeted metabolomics sequencing was employed to profile serum metabolites across these participants. Additionally, individuals from the Healthy Controls (HCs), Acute Carbon Monoxide Poisoning patients (ACOP), Non-Delayed Encephalopathy After ACOP (DEACMP-N), and DEACMP groups (n=3 each) were randomly selected for transcriptome sequencing to identify potential predictive targets and pivotal signaling pathways associated with DEACMP. Furthermore, Severe DEACMP and Control rat models were established. Three rats from the Control, DEACMP, and DEACMP + Dexamethasone + Selenomethionine groups were selected for snRNA-seq. Immunofluorescence multiplexing and qRT-PCR (quantitative Reverse Transcription Polymerase Chain Reaction) were then performed to validate the identified predictive targets.

Results: Analysis of clinical data from 105 participants highlights the pivotal role of inflammation in influencing the prognosis of carbon monoxide poisoning. Metabolomics analysis identified 19 metabolites that significantly differed between the DEACMP-N and DEACMP groups. Transcriptomics analysis of 12 participants indicated that DEACMP is primarily associated with six signaling pathways, including lysosome and tuberculosis. Considering that microglia are central nervous system immune effectors, the sn- RNA-seq analysis revealed altered gene expression and signaling pathways in microglia during DEACMP, with KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis highlighting neutrophil extracellular trap formation, lysosome, and tuberculosis as the predominant pathways. Differential gene analysis from transcriptome and snRNA-seq identified 28 genes differentially expressed in DEACMP. The STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) database, immune multiplexing, and qRT-PCR confirmed the pivotal role of the Ifngr1/Stat1/Ctss axis in DEACMP.

Discussion: This research identifies the Ifngr1/Stat1/Ctss axis as a key inflammatory mechanism in the pathogenesis of DEACMP, thereby clarifying previous uncertainties regarding the sequelae of carbon monoxide poisoning. The intersection of lysosomal and tuberculosis pathways, as revealed through metabolomic, transcriptomic, and single-nucleus RNA sequencing analyses—especially within microglia— offers novel mechanistic insights that could inform therapeutic interventions. While the integration of multiple omics methodologies enhances the robustness of these findings, their biological relevance to the pathogenesis of DEACMP requires rigorous validation through independent cohort verification approaches.

Conclusion: This study provides a comprehensive overview of serum metabolite expression, differential gene expression, and signaling pathways in DEACMP, offering a theoretical foundation for understanding the pathogenesis of DEACMP.

Keywords: DEACMP, carbon monoxide poisoning, microglia, neuroinflammation, multi-omics, snRNA-seq.

[1]
Chenoweth, J.A.; Albertson, T.E.; Greer, M.R. Carbon monoxide poisoning. Crit. Care Clin., 2021, 37(3), 657-672.
[http://dx.doi.org/10.1016/j.ccc.2021.03.010] [PMID: 34053712]
[2]
Kinoshita, H.; Türkan, H.; Vucinic, S.; Naqvi, S.; Bedair, R.; Rezaee, R.; Tsatsakis, A. Carbon monoxide poisoning. Toxicol. Rep., 2020, 7, 169-173.
[http://dx.doi.org/10.1016/j.toxrep.2020.01.005] [PMID: 32015960]
[3]
Wang, R.; Li, K.; Wang, Z.; Wang, Y.; Zhang, H. Changes of nuclear factor Kappa-B pathway activity in hippocampus after acute carbon monoxide poisoning and its role in nerve cell injury. Mol. Neurobiol., 2024, 61(8), 5206-5215.
[http://dx.doi.org/10.1007/s12035-023-03889-5] [PMID: 38172287]
[4]
Liao, S.C.; Shao, S.C.; Yang, K.J.; Yang, C.C. Real-world effectiveness of hyperbaric oxygen therapy for delayed neuropsychiatric sequelae after carbon monoxide poisoning. Sci. Rep., 2021, 11(1), 19212.
[http://dx.doi.org/10.1038/s41598-021-98539-y] [PMID: 34584153]
[5]
Wang, Y.; Zhou, Z.; Zhang, D.; Jiang, Y. Predictors of delayed encephalopathy after acute carbon monoxide poisoning: A literature review. Front. Med. (Lausanne), 2025, 12, 1559264.
[http://dx.doi.org/10.3389/fmed.2025.1559264] [PMID: 40206479]
[6]
Thom, S.R.; Bhopale, V.M.; Fisher, D. Hyperbaric oxygen reduces delayed immune-mediated neuropathology in experimental carbon monoxide toxicity. Toxicol. Appl. Pharmacol., 2006, 213(2), 152-159.
[http://dx.doi.org/10.1016/j.taap.2005.10.006] [PMID: 16325878]
[7]
Zhang, J.; Guo, Y.; Li, W.; Li, G.; Chen, Y. The efficacy of N-butylphthalide and dexamethasone combined with hyperbaric oxygen on delayed encephalopathy after acute carbon monoxide poisoning. Drug Des. Devel. Ther., 2020, 14, 1333-1339.
[http://dx.doi.org/10.2147/DDDT.S217010] [PMID: 32308366]
[8]
Arya, A. K.; Sethuraman, K.; Waddell, J.; Cha, Y. S.; Liang, Y.; Bhopale, V. M.; Bhat, A. R.; Imtiyaz, Z.; Dakessian, A.; Lee, Y. Inflammatory responses to acute carbon monoxide poisoning and the role of plasma gelsolin. Sci Adv, 2025, 11(6), ead9751.
[http://dx.doi.org/10.1126/sciadv.ado9751]
[9]
Peng, Z-R.; Huang, Y-Q.; Huang, F.L.; Yang, A.L. Mechanism of delayed encephalopathy after acute carbon monoxide poisoning. Neural Regen. Res., 2020, 15(12), 2286-2295.
[http://dx.doi.org/10.4103/1673-5374.284995] [PMID: 32594050]
[10]
Pang, L.; Zhang, N.; Dong, N.; Wang, D.W.; Xu, D.H.; Zhang, P.; Meng, X.W. Erythropoietin protects rat brain injury from carbon monoxide poisoning by inhibiting toll- like receptor 4/NF-kappa B-dependent inflammatory responses. Inflammation, 2016, 39(2), 561-568.
[http://dx.doi.org/10.1007/s10753-015-0280-4] [PMID: 26521252]
[11]
Lenz, K.M.; Nelson, L.H. Microglia and beyond: Innate immune cells as regulators of brain development and behavioral function. Front Immunol, 2018, 9, 698.
[http://dx.doi.org/10.3389/fimmu.2018.00698] [PMID: 29740446]
[12]
Leng, F.; Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat. Rev. Neurol., 2021, 17(3), 157-172.
[http://dx.doi.org/10.1038/s41582-020-00435-y] [PMID: 33318676]
[13]
Hu, Y.; Li, Z.; Zhu, Y.; Xing, M.; Xie, X.; Zhao, P.; Cheng, X.; Xiao, C.; Xia, Y.; Wu, J.; Luo, Y.; Ko, H.; Tang, Y.; Ye, X.; Lin, W.J. Microglial repopulation reverses radiation-induced cognitive dysfunction by restoring medial prefrontal cortex activity and modulating leukotriene-C4 synthesis. Acta Neuropathol. Commun., 2025, 13(1), 105.
[http://dx.doi.org/10.1186/s40478-025-02026-8] [PMID: 40390112]
[14]
Wolf, S.A.; Boddeke, H.W.G.M.; Kettenmann, H. Microglia in physiology and disease. Annu. Rev. Physiol., 2017, 79(1), 619-643.
[http://dx.doi.org/10.1146/annurev-physiol-022516-034406] [PMID: 27959620]
[15]
Sekiya, K.; Nishihara, T.; Abe, N.; Konishi, A.; Nandate, H.; Hamada, T.; Ikemune, K.; Takasaki, Y.; Tanaka, J.; Asano, M.; Yorozuya, T. Carbon monoxide poisoning–induced delayed encephalopathy accompanies decreased microglial cell numbers: Distinctive pathophysiological features from hypoxemia–induced brain damage. Brain Res., 2019, 1710, 22-32.
[http://dx.doi.org/10.1016/j.brainres.2018.12.027] [PMID: 30578768]
[16]
Omaye, S.T. Metabolic modulation of carbon monoxide toxicity. Toxicology, 2002, 180(2), 139-150.
[http://dx.doi.org/10.1016/S0300-483X(02)00387-6]
[17]
Liu, Z.; Wang, L.; Lian, J.; Li, S.; Zhao, L.; Li, H.L. Analysis of factors associated with the development of delayed encephalopathy following acute carbon monoxide poisoning. Sci. Rep., 2024, 14(1), 14630.
[http://dx.doi.org/10.1038/s41598-024-64424-7] [PMID: 38918432]
[18]
Wang, S.; Han, W.; Sun, T.; Wang, H.; Zhang, Z.; Li, H. Development of a nomogram based on diffusion-weighted imaging and clinical information to predict delayed encephalopathy after acute carbon monoxide poisoning. J. Integr. Neurosci., 2023, 22(6), 165.
[http://dx.doi.org/10.31083/j.jin2206165]
[19]
Runming, S.; Wenyuan, C.; Zhangge, J.; Wenwen, B.; Lixia, W.; Qian, W.; Zhaodong, L. Predictive values of serum biochemical markers and apparent diffusion coefficient on delayed encephalopathy after acute carbon monoxide poisoning. Turk Neurosurg., 2020, 31(6), 851-856.
[http://dx.doi.org/10.5137/1019-5149.JTN.30830-20.2] [PMID: 33759155]
[20]
Yan, H.; Yuan, D.; Zhang, Y.; Luo, H.; Jiang, P.; Zhang, Y.; Wu, Y.; Hou, L.; Cheng, Y.; Yang, F.; Du, Y.; Zhu, H.; Zhao, L.; Li, Y.; Jiang, Y.; Gao, Y. Integration of methylation and gene expression deciphered candidate biomarkers DAB2IP and SMYD3 in delayed encephalopathy after carbon monoxide poisoning. CNS Neurosci. Ther., 2025, 31(2), e70270.
[http://dx.doi.org/10.1111/cns.70270] [PMID: 39953812]
[21]
Huang, Y.; Ye, Z.; Ma, T.; Li, H.; Zhao, Y.; Chen, W.; Wang, Y.; Yan, X.; Gao, Y.; Li, Z. Carbon monoxide (CO) modulates hydrogen peroxide (H2O2)-mediated cellular dysfunction by targeting mitochondria in rabbit lens epithelial cells. Exp. Eye Res., 2018, 169, 68-78.
[http://dx.doi.org/10.1016/j.exer.2018.01.023] [PMID: 29407220]
[22]
Liu, X.L.; Guan, L. Research progress on head imaging features of carbon monoxide poisoning and delayed encephalopathy. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, 2023, 41(1), 57-62.
[http://dx.doi.org/10.3760/cma.j.cn121094-20220223-00088] [PMID: 36725298]
[23]
Rose, J.J.; Wang, L.; Xu, Q.; McTiernan, C.F.; Shiva, S.; Tejero, J.; Gladwin, M.T. Carbon monoxide poisoning: Pathogenesis, management, and future directions of therapy. Am. J. Respir. Crit. Care Med., 2017, 195(5), 596-606.
[http://dx.doi.org/10.1164/rccm.201606-1275CI] [PMID: 27753502]
[24]
Paganini, M.; Thom, S.R. Editorial: Carbon monoxide poisoning: Updates on prevention, diagnosis, and treatment. Front. Med. (Lausanne), 2024, 11, 1411547.
[http://dx.doi.org/10.3389/fmed.2024.1411547] [PMID: 38690173]
[25]
Ji, L.; Chen, S.; Gu, G.; Wang, W.; Ren, J.; Xu, F.; Li, F.; Wu, J.; Yang, D.; Zheng, Y. Discovery of potential biomarkers for human atherosclerotic abdominal aortic aneurysm through untargeted metabolomics and transcriptomics. J. Zhejiang. Univ. Sci, 2021, 22(9), 733.
[http://dx.doi.org/10.1631/jzus.B2000713]
[26]
Fu, Y.; Wang, C.; Wu, Z.; Zhang, X.; Liu, Y.; Wang, X.; Liu, F.; Chen, Y.; Zhang, Y.; Zhao, H.; Wang, Q. Discovery of the potential biomarkers for early diagnosis of endometrial cancer via integrating metabolomics and transcriptomics. Comput. Biol. Med., 2024, 173, 108327.
[http://dx.doi.org/10.1016/j.compbiomed.2024.108327] [PMID: 38552279]
[27]
Wolf, S.J.; Maloney, G.E.; Shih, R.D.; Shy, B.D.; Brown, M.D.; Brown, M.D.; Byyny, R.; Diercks, D.B.; Gemme, S.R.; Gerardo, C.J.; Godwin, S.A.; Hahn, S.A.; Hatten, B.W.; Haukoos, J.S.; Ingalsbe, G.S.; Kaji, A.; Kwok, H.; Lo, B.M.; Mace, S.E.; Nazarian, D.J.; Proehl, J.A.; Promes, S.B.; Shah, K.H.; Shih, R.D.; Silvers, S.M.; Smith, M.D.; Thiessen, M.E.W.; Tomaszewski, C.A.; Valente, J.H.; Wall, S.P.; Wolf, S.J.; Cantrill, S.V.; O’Connor, R.E.; Mitchell, M.A.; Whitson, R.R. Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with acute carbon monoxide poisoning. Ann. Emerg. Med., 2017, 69(1), 98-107.e6.
[http://dx.doi.org/10.1016/j.annemergmed.2016.11.003] [PMID: 27993310]
[28]
Qin, P.; Ho, F.K.; Celis-Morales, C.A.; Pell, J.P. Association between systemic inflammation biomarkers and incident cardiovascular disease in 423,701 individuals: evidence from the UK biobank cohort. Cardiovasc. Diabetol., 2025, 24(1), 162.
[http://dx.doi.org/10.1186/s12933-025-02721-9] [PMID: 40234895]
[29]
Yang, C.H.; Wang, X.Y.; Zhang, Y.H.; Ding, N. SIRI and SII as potential biomarkers of disease activity and lupus nephritis in systemic lupus erythematosus. Front. Immunol., 2025, 16, 1530534.
[http://dx.doi.org/10.3389/fimmu.2025.1530534] [PMID: 39958362]
[30]
Karnovsky, A.; Li, S. Pathway analysis for targeted and untargeted metabolomics. Methods Mol. Biol., 2020, 2104, 387-400.
[http://dx.doi.org/10.1007/978-1-0716-0239-3_19] [PMID: 31953827]
[31]
Shen, M.; Fan, D.; Zang, Y.; Chen, Y.; Zhu, K.; Cai, Z.; Liu, Y.; Sun, X.; Liu, J.; Gong, J. Neuroprotective effects of methane-rich saline on experimental acute carbon monoxide toxicity. J. Neurol. Sci., 2016, 369, 361-367.
[http://dx.doi.org/10.1016/j.jns.2016.08.055] [PMID: 27653924]
[32]
Atalay, H.; Aybek, H.; Koseoglu, M.; Demir, S.; Erbay, H.; Bolaman, A.Z.; Avci, A. The effects of amifostine and dexamethasone on brain tissue lipid peroxidation during oxygen treatment of carbon monoxide-poisoned rats. Adv. Ther., 2006, 23(2), 332-341.
[http://dx.doi.org/10.1007/BF02850138] [PMID: 16751165]
[33]
Huang, C.; Guo, Y.; Li, T.; Sun, G.; Yang, J.; Wang, Y.; Xiang, Y.; Wang, L.; Jin, M.; Li, J.; Zhou, Y.; Han, B.; Huang, R.; Qiu, J.; Tan, Y.; Hu, J.; Wei, Y.; Wu, B.; Mao, Y.; Lei, L.; Song, X.; Li, S.; Wang, Y.; Zhang, T. Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy. Redox Biol., 2024, 70, 103024.
[http://dx.doi.org/10.1016/j.redox.2023.103024] [PMID: 38232458]
[34]
Li, J.; Jia, M.; Chen, G.; Nie, S.; Zheng, C.; Zeng, W.; Xu, Y.; Wang, C.; Cao, X.; Liu, Q. Involvement of p38 mitogen-activated protein kinase in altered expressions of AQP1 and AQP4 after carbon monoxide poisoning in rat astrocytes. Basic Clin. Pharmacol. Toxicol., 2019, 125(4), 394-404.
[http://dx.doi.org/10.1111/bcpt.13247] [PMID: 31063681]
[35]
Garaschuk, O.; Verkhratsky, A. Physiology of microglia. Methods Mol. Biol., 2019, 2034, 27-40.
[http://dx.doi.org/10.1007/978-1-4939-9658-2_3] [PMID: 31392675]
[36]
Cassiano, L.M.G.; Oliveira, M.S.; Pioline, J.; Salim, A.C.M.; Coimbra, R.S. Neuroinflammation regulates the balance between hippocampal neuron death and neurogenesis in an ex vivo model of thiamine deficiency. J. Neuroinflammation, 2022, 19(1), 272.
[http://dx.doi.org/10.1186/s12974-022-02624-6] [PMID: 36376954]
[37]
Hampson, N.B. Cost of accidental carbon monoxide poisoning: A preventable expense. Prev. Med. Rep., 2016, 3, 21-24.
[http://dx.doi.org/10.1016/j.pmedr.2015.11.010] [PMID: 26844181]
[38]
Thom, S.R.; Bhopale, V.M.; Han, S.T.; Clark, J.M.; Hardy, K.R. Intravascular neutrophil activation due to carbon monoxide poisoning. Am. J. Respir. Crit. Care Med., 2006, 174(11), 1239-1248.
[http://dx.doi.org/10.1164/rccm.200604-557OC] [PMID: 16931637]
[39]
Bağcı, Z.; Arslan, A.; Arslan, D. The value of neutrophil: Lymphocyte ratio and platelet: Lymphocyte ratio in predicting clinical severity in children with carbon monoxide poisoning. Indian J. Pediatr., 2021, 88(11), 1121-1126.
[http://dx.doi.org/10.1007/s12098-021-03704-w] [PMID: 33725287]
[40]
Yalçın, G.; Tunca, H.; Sayinbatur, B.; Anil, M. Predictive value of complete blood count, venous blood gas measurements, and glucose/potassium ratio for delayed neuropsychiatric syndrome in children with acute carbon monoxide poisoning due to Coal-Burning stove. Turk. Arch. Pediatr., 2023, 58(3), 328-335.
[http://dx.doi.org/10.5152/TurkArchPediatr.2023.22282] [PMID: 37144268]
[41]
Moon, J.M.; Chun, B.J.; Cho, Y.S. The predictive value of scores based on peripheral complete blood cell count for long-term neurological outcome in acute carbon monoxide intoxication. Basic Clin. Pharmacol. Toxicol., 2019, 124(4), 500-510.
[http://dx.doi.org/10.1111/bcpt.13157] [PMID: 30372579]
[42]
Qi, Q.; Zhuang, L.; Shen, Y.; Geng, Y.; Yu, S.; Chen, H.; Liu, L.; Meng, Z.; Wang, P.; Chen, Z. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer, 2016, 122(14), 2158-2167.
[http://dx.doi.org/10.1002/cncr.30057] [PMID: 27152949]
[43]
Johnson, C.H.; Ivanisevic, J.; Siuzdak, G. Metabolomics: Beyond biomarkers and towards mechanisms. Nat. Rev. Mol. Cell Biol., 2016, 17(7), 451-459.
[http://dx.doi.org/10.1038/nrm.2016.25] [PMID: 26979502]
[44]
Hannun, Y.A.; Obeid, L.M. Principles of bioactive lipid signalling: Lessons from sphingolipids. Nat. Rev. Mol. Cell Biol., 2008, 9(2), 139-150.
[http://dx.doi.org/10.1038/nrm2329] [PMID: 18216770]
[45]
Maceyka, M.; Spiegel, S. Sphingolipid metabolites in inflammatory disease. Nature, 2014, 510(7503), 58-67.
[http://dx.doi.org/10.1038/nature13475] [PMID: 24899305]
[46]
Testerink, N.; van der Sanden, M.H.M.; Houweling, M.; Helms, J.B.; Vaandrager, A.B. Depletion of phosphatidylcholine affects endoplasmic reticulum morphology and protein traffic at the Golgi complex. J. Lipid Res., 2009, 50(11), 2182-2192.
[http://dx.doi.org/10.1194/jlr.M800660-JLR200] [PMID: 19458387]
[47]
Slijkhuis, N.; Razzi, F.; Korteland, S.A.; Heijs, B.; van Gaalen, K.; Duncker, D.J.; van der Steen, A.F.W.; van Steijn, V.; van Beusekom, H.M.M.; van Soest, G. Spatial lipidomics of coronary atherosclerotic plaque development in a familial hypercholesterolemia swine model. J. Lipid Res., 2024, 65(2), 100504.
[http://dx.doi.org/10.1016/j.jlr.2024.100504] [PMID: 38246237]
[48]
Grant, G.E.; Gravel, S.; Guay, J.; Patel, P.; Mazer, B.D.; Rokach, J.; Powell, W.S. 5-Oxo-ETE is a major oxidative stress-induced arachidonate metabolite in B lymphocytes. Free Radic. Biol. Med., 2011, 50(10), 1297-1304.
[http://dx.doi.org/10.1016/j.freeradbiomed.2011.02.010] [PMID: 21334434]
[49]
Choque, B.; Catheline, D.; Rioux, V.; Legrand, P. Linoleic acid: Between doubts and certainties. Biochimie, 2014, 96, 14-21.
[http://dx.doi.org/10.1016/j.biochi.2013.07.012] [PMID: 23900039]
[50]
Kang, C.; Kim, J.; Ju, S.; Cho, H.; Kim, H.Y.; Yoon, I.S.; Yoo, J.W.; Jung, Y. Colon-targeted trans-cinnamic acid ameliorates rat colitis by activating GPR109A. Pharmaceutics, 2022, 15(1), 41.
[http://dx.doi.org/10.3390/pharmaceutics15010041] [PMID: 36678670]
[51]
Yang, H.T.; Chen, J.W.; Rathod, J.; Jiang, Y.Z.; Tsai, P.J.; Hung, Y.P.; Ko, W.C.; Paredes-Sabja, D.; Huang, I.H. Lauric acid is an inhibitor of Clostridium difficile Growth in Vitro and reduces inflammation in a mouse infection model. Front. Microbiol., 2018, 8, 2635.
[http://dx.doi.org/10.3389/fmicb.2017.02635] [PMID: 29387044]
[52]
Panda, S.P.; Kesharwani, A.; Singh, M.; Kumar, S.; Mayank; Mallick, S.P.; Guru, A. Limonin (LM) and its derivatives: Unveiling the neuroprotective and anti-inflammatory potential of LM and V-A-4 in the management of Alzheimer’s disease and Parkinson’s disease. Fitoterapia, 2024, 178, 106173.
[http://dx.doi.org/10.1016/j.fitote.2024.106173] [PMID: 39117089]
[53]
Javed, M.; Ahmad, M.I.; Javed, H.; Naseem, S. d-ribose and pathogenesis of Alzheimer’s disease. Mol. Biol. Rep., 2020, 47(3), 2289-2299.
[http://dx.doi.org/10.1007/s11033-020-05243-7] [PMID: 31933261]
[54]
Mathys, H.; Davila-Velderrain, J.; Peng, Z.; Gao, F.; Mohammadi, S.; Young, J.Z.; Menon, M.; He, L.; Abdurrob, F.; Jiang, X.; Martorell, A.J.; Ransohoff, R.M.; Hafler, B.P.; Bennett, D.A.; Kellis, M.; Tsai, L.H. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature, 2019, 570(7761), 332-337.
[http://dx.doi.org/10.1038/s41586-019-1195-2] [PMID: 31042697]
[55]
Wang, C.; Zou, Q.; Pu, Y.; Cai, Z.; Tang, Y. Berberine rescues D-Ribose-induced Alzheimer’s pathology via promoting mitophagy. Int. J. Mol. Sci., 2023, 24(6), 5896.
[http://dx.doi.org/10.3390/ijms24065896] [PMID: 36982968]
[56]
Wu, B.; Wei, Y.; Wang, Y.; Su, T.; Zhou, L.; Liu, Y.; He, R. Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety- like behavior in mice. Oncotarget, 2015, 6(33), 34128-34142.
[http://dx.doi.org/10.18632/oncotarget.6021] [PMID: 26452037]
[57]
Potter, C.B.; Davis, M.T.; Albadarin, A.B.; Walker, G.M. Investigation of the dependence of the flory-huggins interaction parameter on temperature and composition in a drug–polymer system. Mol. Pharm., 2018, 15(11), 5327-5335.
[http://dx.doi.org/10.1021/acs.molpharmaceut.8b00797] [PMID: 30259745]
[58]
Rana, D.; Mandal, B.M.; Bhattacharyya, S.N. Analogue calorimetric studies of blends of poly(vinyl ester)s and Polyacrylates. Macromolecules, 1996, 29(5), 1579-1583.
[http://dx.doi.org/10.1021/ma950954n]
[59]
Rana, D.; Mandal, B.M.; Bhattacharyya, S.N. Analogue calorimetry of polymer blends: poly(styrene-co-acrylonitrile) and poly(phenyl acrylate) or poly(vinyl benzoate). Polymer (Guildf.), 1996, 37(12), 2439-2443.
[http://dx.doi.org/10.1016/0032-3861(96)85356-0]
[60]
Rana, D.; Mandal, B.M.; Bhattacharyya, S.N. Miscibility and phase diagrams of poly(phenyl acrylate) and poly(styrene-co-acrylonitrile) blends. Polymer (Guildf.), 1993, 34(7), 1454-1459.
[http://dx.doi.org/10.1016/0032-3861(93)90861-4]
[61]
Tian, Y.; Booth, J.; Meehan, E.; Jones, D.S.; Li, S.; Andrews, G.P. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions. Mol. Pharm., 2013, 10(1), 236-248.
[http://dx.doi.org/10.1021/mp300386v] [PMID: 23110477]
[62]
Leung, S.S.W.; Busto, J.V.; Keyvanloo, A.; Goñi, F.M.; Thewalt, J. Insights into sphingolipid miscibility: separate observation of sphingomyelin and ceramide N-acyl chain melting. Biophys. J., 2012, 103(12), 2465-2474.
[http://dx.doi.org/10.1016/j.bpj.2012.10.041] [PMID: 23260048]
[63]
Virk, R.; Cook, K.; Cavazos, A.; Wassall, S.R.; Gowdy, K.M.; Shaikh, S.R. How membrane phospholipids containing long-chain polyunsaturated fatty acids and their oxidation products orchestrate lipid raft dynamics to control inflammation. J. Nutr., 2024, 154(9), 2862-2870.
[http://dx.doi.org/10.1016/j.tjnut.2024.07.015] [PMID: 39025329]
[64]
Drücker, P.; Gerke, V.; Galla, H.J. Importance of phospholipid bilayer integrity in the analysis of protein–lipid interactions. Biochem. Biophys. Res. Commun., 2014, 453(1), 143-147.
[http://dx.doi.org/10.1016/j.bbrc.2014.09.079] [PMID: 25264195]
[65]
San Biagio, P.L.; Palma, M.U. Spinodal lines and Flory-Huggins free-energies for solutions of human hemoglobins HbS and HbA. Biophys. J., 1991, 60(2), 508-512.
[http://dx.doi.org/10.1016/S0006-3495(91)82078-1] [PMID: 1912284]
[66]
Hannesschlaeger, C.; Horner, A.; Pohl, P. Intrinsic membrane permeability to small molecules. Chem. Rev., 2019, 119(9), 5922-5953.
[http://dx.doi.org/10.1021/acs.chemrev.8b00560] [PMID: 30951292]
[67]
Lingwood, D.; Simons, K. Lipid rafts as a membrane-organizing principle. Science, 2010, 327(5961), 46-50.
[http://dx.doi.org/10.1126/science.1174621] [PMID: 20044567]
[68]
Reigada, R.; Sagués, F. Chloroform alters interleaflet coupling in lipid bilayers: An entropic mechanism. J. R. Soc. Interface, 2015, 12(106), 20150197.
[http://dx.doi.org/10.1098/rsif.2015.0197] [PMID: 25833246]
[69]
Nerenberg, P.S.; Jo, B.; So, C.; Tripathy, A.; Head-Gordon, T. Optimizing solute-water van der Waals interactions to reproduce solvation free energies. J. Phys. Chem. B, 2012, 116(15), 4524-4534.
[http://dx.doi.org/10.1021/jp2118373] [PMID: 22443635]
[70]
Sobue, A.; Komine, O.; Yamanaka, K. Neuroinflammation in Alzheimer’s disease: Microglial signature and their relevance to disease. Inflamm. Regen., 2023, 43(1), 26.
[http://dx.doi.org/10.1186/s41232-023-00277-3] [PMID: 37165437]
[71]
Liu, C.L.; Guo, J.; Zhang, X.; Sukhova, G.K.; Libby, P.; Shi, G.P. Cysteine protease cathepsins in cardiovascular disease: From basic research to clinical trials. Nat. Rev. Cardiol., 2018, 15(6), 351-370.
[http://dx.doi.org/10.1038/s41569-018-0002-3] [PMID: 29679024]
[72]
Nakanishi, H. Cathepsin regulation on microglial function. Biochim. Biophys. Acta. Proteins Proteomics, 2020, 1868(9), 140465.
[http://dx.doi.org/10.1016/j.bbapap.2020.140465] [PMID: 32526473]
[73]
Wilkinson, R.D.A.; Williams, R.; Scott, C.J.; Burden, R.E. Cathepsin S: Therapeutic, diagnostic, and prognostic potential. Biol. Chem., 2015, 396(8), 867-882.
[http://dx.doi.org/10.1515/hsz-2015-0114] [PMID: 25872877]
[74]
Ramana, C.V.; Gil, M.P.; Schreiber, R.D.; Stark, G.R. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol., 2002, 23(2), 96-101.
[http://dx.doi.org/10.1016/S1471-4906(01)02118-4] [PMID: 11929133]
[75]
Smyth, P.; Sasiwachirangkul, J.; Williams, R.; Scott, C.J. Cathepsin S (CTSS) activity in health and disease: A treasure trove of untapped clinical potential. Mol Aspects Med., 2022, 88, 101106.
[http://dx.doi.org/10.1016/j.mam.2022.101106]
[76]
Gros, F.; Muller, S. The role of lysosomes in metabolic and autoimmune diseases. Nat. Rev. Nephrol., 2023, 19(6), 366-383.
[http://dx.doi.org/10.1038/s41581-023-00692-2] [PMID: 36894628]
[77]
Tiwari, D.; Martineau, A.R. Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies. Semin. Immunol., 2023, 65, 101672.
[http://dx.doi.org/10.1016/j.smim.2022.101672]

Rights & Permissions Print Cite